Investor Relations
Press releases 2021
Regulatory press release
ADDvise signs Letter of Intent to acquire JTECH Medical Industries, Inc.
Regulatory press release
ADDvise Group publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm
Regulatory press release
ADDvise Group calls for a change of the terms of the company’s senior secured bonds by initiation of a written procedure
Regulatory press release
ADDvise receives allocation decision worth approximately EUR 5 million
Regulatory press release
ADDvise acquires Southern Life Systems, Inc.
Regulatory press release
ADDvise Group appoints interim CFO
Regulatory press release
ADDvise receives order worth USD 530,000
Regulatory press release
ADDvise receives order worth USD 800,000
Regulatory press release
ADDvise receives order worth USD 1.8 million
Regulatory press release
ADDvise Group successfully issues subsequent senior secured bonds of 250 MSEK
Regulatory press release
ADDvise Group investigates the possibility to issue subsequent senior secured bonds
Regulatory press release
Interim report 2021, January 1 – September 30
Regulatory press release
ADDvise Group appoints new CFO
Regulatory press release
ADDvise signs Letter of Intent to acquire Poly Pharmaceuticals, Inc.
Regulatory press release
ADDvise Group’s nomination committee for the Annual General Meeting 2022
Regulatory press release
ADDvise Group’s reporting dates 2022
Regulatory press release
On account of the difference in price movements in ADDvise Group’s shares
Regulatory press release
ADDvise updates long-term financial goals
Regulatory press release
ADDvise acquires Graham Medical Technologies, LLC
Regulatory press release
ADDvise Group completes a directed new share issue of approximately SEK 125 million which was multiple times oversubscribed
Regulatory press release
ADDvise Group announces intention to carry out a directed new share issue of approximately SEK 125 million
Regulatory press release
ADDvise signs Letter of Intent to acquire Southern Life Systems, Inc.
Regulatory press release
ADDvise strengthens the management team, recruits COO
Regulatory press release
ADDvise completes the acquisition of Medisuite, LLC
Regulatory press release
ADDvise acquires Medisuite, LLC
Regulatory press release
ADDvise Group’s CFO Aaron Wong resigns
Regulatory press release
Interim report 2021, January 1 – June 30
Regulatory press release
ADDvise Group publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm
Regulatory press release
ADDvise completes the acquisition of MRC Systems FZE
Regulatory press release
ADDvise Group AB (publ) to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds with ISIN SE0010298166
Regulatory press release
ADDvise signs Letter of Intent to acquire Medisuite, LLC
Regulatory press release
ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds
Regulatory press release
ADDvise Group issues a senior secured bond loan of 250 MSEK
Regulatory press release
ADDvise Group investigates the possibility to issue secured bonds
Regulatory press release
ADDvise received order worth SEK 9 million
Regulatory press release
ADDvise signs Letter of Intent to acquire Graham Medical Technologies, L.L.C.
Regulatory press release
Interim report 2021, January 1 – March 31
Regulatory press release
ADDvise Group AB (publ) publishes the 2020 annual report – Regulatory information
Regulatory press release
The nomination committee’s proposal of board of directors in ADDvise Group AB (publ) – Regulatory information
Regulatory press release
ADDvise Group acquires MRC Systems FZE – Regulatory information
Regulatory press release
ADDvise Group AB receives SEK 27.8 million through the warrants of series 2019/2021 – Regulatory information
Regulatory press release
Last day of trading in warrants of series 2019/2021 is February 4, 2021 – Regulatory information
Regulatory press release
Result update Q4, full year 2020 and the board of directors’ dividend proposal – Regulatory information
Regulatory press release
The subscription period for warrants of series 2019/2021 begins today – Regulatory information
Regulatory press release